Amyn A. Malik, MBBS, MPH, PhD

Epidemiologist; Assistant Professor, Epidemiology at O'Donnell School of Public Health, UTSW @utswosph; TB and ID researcher

[Krutika Kuppalli, MD FIDSA @KrutikaKuppalli]

Given ongoing conversations around #measles and #vaccines, I wanted to share our poster on measles vaccine intentions among Canadians- currently presented at #ESCMIDGlobal2026

A similar study in the U.S. observed comparable patterns of hesitancy—a concerning signal as measles resurges globally.

[Krutika Kuppalli, MD FIDSA @KrutikaKuppalli]

So grateful to the incredible co-authors from @UTSWMedCenter and @utswosph who made this work possible @amynmalik ,Jad Elharake, Hannah Melchinger and @SaadOmer3

Thank you for being such amazing collaborators. 🙏✨

[Krutika Kuppalli, MD FIDSA @KrutikaKuppalli]

🚨🆕 Excited to share our new paper on #measles #vaccination attitudes in the United States🇺🇸 published in the #Lancet Regional Health - Americas

As measles cases surge 📈 to the highest levels since elimination in 2000, we wanted to understand U.S. adults intention to vaccinate children against measles

Here’s what we found. 🧵👇
https://t.co/NjsqXgLHC2

[Krutika Kuppalli, MD FIDSA @KrutikaKuppalli]

Excited to share our new paper in Vaccine! We surveyed US adults on #mpox Clade Ib awareness, attitudes, and #vaccine intent.

Findings: 58% would vaccinate if recommended—up from 2022—but gaps in knowledge and trust remain.

Thanks to brilliant coauthors @amynmalik @saadomer3 Hannah Melchinger, Maya Khemsara, Noureen Ahmed, Sameer Belgaumi!

📄 https://t.co/zn7q4tJsB5
#mpox #Vaccines #InfectiousDiseases

[Clinical Infectious Diseases @CIDJournal]

Tuberculosis preventive treatment for household contacts at health facility and community settings in Pakistan

✅ Just Accepted
✍️ @amynmalik
🔗 https://t.co/cIvCjfdR6p

[Amyn A. Malik, MBBS, MPH, PhD @amynmalik]

@EpiEllie We are all mortals after all.

[Finn McQuaid @CFMcQuaid]

Are pan-TB treatment regimens likely to drive the emergence of novel drug resistance? We investigated, in a new paper here https://t.co/XkFr0o1sMv with @emilyakendall @NickMenzies2 @richardwhite321 @ted_h_cohen @rycktessman @LSHTM @LSHTM_TB @cmmid_lshtm @lshtm_tbmod

[Amyn A. Malik, MBBS, MPH, PhD @amynmalik]

@CFMcQuaid @IRDGlobal @LSHTM @TBMAC @TB_MAC

#contacttracing #tuberculosis

[Amyn A. Malik, MBBS, MPH, PhD @amynmalik]

Most TB programs focus on a subset of household contacts for contact management leaving many contacts unscreened. We show that the yield from tracing contacts of guidelines ineligible patients is similar to guidelines eligible patients.

@utswosph

https://t.co/w0cTj0KNRy

[Amyn A. Malik, MBBS, MPH, PhD @amynmalik]

Household contacts of not tested patients are not contact traced resulting in missed opportunities for early diagnosis & transmission prevention. Expanding contact tracing strategies under such conditions can improve diagnosis. However, studies are needed to establish feasibility

[Amyn A. Malik, MBBS, MPH, PhD @amynmalik]

A massive effort led by @LaurenPischel and team. The VE of 2 dose MVA-BN is 82% against Mpox.

https://t.co/czI23PEzNi

#medtwitter #epidemiology

@utswosph

[Lauren Pischel, MD MSc @LaurenPischel]

Pleased to share our latest publication in Vaccine on the vaccine effectiveness of JYNNEOS vaccines (MVA-BN). Overall these are highly effective at preventing mpox. You can find the systematic review/meta analysis here: https://t.co/4TEYFreZZT

[Amyn A. Malik, MBBS, MPH, PhD @amynmalik]

Amazing work! This paper provides a nuanced analysis of who benefits the most from TPT and in what context.

Fortunate to work with an amazing team on this.

#medtwitter @utswosph

[Meredith Brooks, PhD, MPH @MeredithBBrooks]

Had a great time at the @union_tblh NAR and @tbcontrollers meeting in Baltimore this week. Always a pleasure running into old friends, meeting new friends, and introducing new trainees to our welcoming community.
@tiara_boston @BUSPH #endTB

[Amyn A. Malik, MBBS, MPH, PhD @amynmalik]

@ashtroid22 I have it in my office in Dallas. But traveling till the weekend. Can do when in office Monday if that works

[Amyn A. Malik, MBBS, MPH, PhD @amynmalik]

Thank you @s_keshavjee for the wonderful talk!

[O'Donnell School of Public Health at UTSW @utswosph]

OSPH had a fantastic time participating in the World Tuberculosis Day events! Thank you @StopTB for the vibrant red scarves, adding a powerful symbol to our collective commitment in the fight against TB. Together, we raise awareness and advocate for a tuberculosis-free world.

[Amyn A. Malik, MBBS, MPH, PhD @amynmalik]

On this #WorldTBDay2024, join us at @utswosph for a talk by @s_keshavjee on TB Elimination: Challenges, Barriers, and Gaps. What can we do differently?

@StopTB @harvardmed

[O'Donnell School of Public Health at UTSW @utswosph]

Join us on March 26th, 8-9 AM CST, for an event honoring World TB Day with Dr. Salmaan Keshavjee from Harvard Medical School! He'll discuss "TB Elimination: Challenges, barriers, and gaps. What can we do differently?" In-person in & Teams available.

[Amyn A. Malik, MBBS, MPH, PhD @amynmalik]

Our individual patient data meta-analysis shows levofloxacin exposures at current WHO-recommended doses is below the AUC target for children. Revised weight-band dosing guidelines of >20 mg/kg required.

@utswosph @IRDGlobal

#MedTwitter #GlobalHealth

https://t.co/W2fGejxEfh

[Amyn A. Malik, MBBS, MPH, PhD @amynmalik]

@turnbulldugarte Different field but I recently had a reject after R&R as one of the reviewers came back on revision saying we didn't respond to their comments without pointing out which one. We had a point to point response for each of their comments. The other 2 reviewers were very positive